AGP Executive Report
Last update: 9 hours agoPharma: A Dutch court ordered Merck to stop producing and selling injectable Keytruda in eight European markets, including the Netherlands, over a patent dispute with Halozyme. Merck disputes the ruling. Transport: A power cut at Schiphol disrupted Eurostar services, forcing trains to skip the airport station. Shipping: South Korea’s first commercial Arctic round trip to Europe included a Rotterdam stop. The 50-day voyage is part of plans to develop a faster alternative route, though ice, environmental and geopolitical risks remain. Dutch Industry: BAM agreed to acquire infrastructure contractor A.Hak for €504 million as it targets UK growth. In Delfzijl, Perpetual Next and Lhyfe are exploring renewable hydrogen supplies for a biomethanol plant. Innovation: A Dutch AI company says it can design new polymers to specification in weeks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.